
Loading, please wait...

Loading, please wait...

Zydus Lifesciences recently announced the launch of AI glucose monitors in India. These next-generation Continuous Glucose Monitoring (CGM) devices, Diasens and GlucoLive, aim to transform modern diabetes management. By integrating artificial intelligence, Zydus provides a more connected care ecosystem for patients and clinicians alike. Consequently, this technology bridge improves real-time clinical decision-making.
The new CGM systems stream glucose readings to smartphones every three minutes. Furthermore, this ensures an uninterrupted capture of data, even during the night or in emergencies. The integrated AI layer identifies trends and flags hypoglycemic or hyperglycemic episodes immediately. Additionally, the system links these fluctuations to specific food intake and physical activities. Therefore, clinicians can offer more precise, personalized advice to their patients based on comprehensive glycaemic data. Moreover, the automatic streaming eliminates the need for manual logging by the patient.
The technology functions through the TatvaCare GoodFlip application. This app generates actionable insights from complex data sets. Because the app shares data in real-time, caregivers and doctors can intervene more quickly. Such advancements simplify the monitoring process for those living with chronic conditions. Moreover, the closed-loop ecosystem ensures that no critical reading goes unnoticed. This launch strengthens the companion diagnostics portfolio for Zydus in the Indian market.
Q1: How often do the Diasens and GlucoLive devices update glucose readings?
The devices automatically stream glucose readings to the patient’s smartphone every three minutes, ensuring continuous and real-time monitoring.
Q2: What is the primary role of the AI layer in these CGM devices?
The AI layer analyzes data trends to flag hypo- and hyperglycaemic episodes while linking fluctuations to the patient's diet and activity levels.
Q3: Which app is used to view the data from these Zydus AI glucose monitors?
Patients use the TatvaCare GoodFlip app, which provides AI-driven analytics and connects them with clinicians and caregivers.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Zydus Lifesciences introduces AI-powered Diasens and GlucoLive CGM devices in India for real-time glucose tracking and advanced diabetes management insights...
4 months ago

Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today

An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back

A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back

Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back

With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today